Clinical Trial Update: Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of a combination of hydroxychloroquine, pegylated interferon alfa-2a, and ribavirin in adults with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Pegylated Interferon Alpha-2a (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Chronic Hepatitis C | Phase 1, Phase 2 | Status: UNKNOWN